Advancing vein care with a first-of-its-kind replacement valve for veins

THE CONDITION

Poorly functioning vein valves
Video
Arrow@2x
Veins healthy
Arrow@2x
Veins not healthy

THE NEED

Over 10% of the U.S. is affected by poorly functioning valves in the veins of legs and advanced vein disease.
These poorly functioning valves allow blood to flow backward and pool in the legs.
This pooling causes swelling, pain, and recurring leg wounds.
Still, there is no definitive cure.
  1. Recurring leg wounds affect millions in the United States alone.
  2. Management costs billions to the U.S. healthcare system annually.
  3. Current treatment is palliative, leaving up to half this population with recurrent wounds for years to decades.
  4. Others often remain with advanced symptoms including pain, leg swelling, and skin thickening.
  5. Still, there is no option for a prosthetic valve replacement on the market.

THE SOLUTION

InnoVein, a Y Combinator and venture backed medical device company, is developing a first-of-its-kind valve replacement to offer patients their first definitive cure. Its novel award-winning technology is predicated on decades of cardiac and arterial approaches.
Pl img 1@2xDown arrow@2x
Pl img 2@2xDown arrow@2x
Pl img 3@2x

THE TEAM

In aggregate, the InnoVein founding team has invented and brought over 15 medical technologies to market, with leading products selling over $3B. Track record:
Pl avatar austin@2x

Austin Walker

CEO

Oversubscribed multi-million dollar financing • Forbes 30 under 30 • Medical training @ UCSF • Engineering training @ Northwestern
Pl avatar albert@2x

Albert K. Chin, M.D.

Chief Innovation Officer

Commercialized twelve medical device inventions • Co-Founder Guidant Cardiac Surgery • B.S. MIT • M.S. Stanford University • M.D. UCSF
Pl avatar tom@2x

Tom Kramer

COO

Led operations to bring half a dozen medical technologies to market • Experience as COO, VP Clinical, Director R&D • B.S. Cal Pol • M.S. SDSU

RECOGNITION & AWARDS